共 50 条
- [4] REVISED PREDICTIVE BIOMARKER FOR OCRIPLASMIN THERAPY IN VITREOMACULAR TRACTION DISORDERS [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2021, 41 (12): : 2549 - 2555
- [5] Recurrent Vitreomacular Traction in a Patient Treated with Ocriplasmin: A Case Report [J]. Ophthalmology and Therapy, 2021, 10 : 187 - 192
- [9] SAFETY PROFILE OF OCRIPLASMIN FOR THE PHARMACOLOGIC TREATMENT OF SYMPTOMATIC VITREOMACULAR ADHESION/TRACTION [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (06): : 1111 - 1127
- [10] SAFETY PROFILE OF OCRIPLASMIN FOR SYMPTOMATIC VITREOMACULAR ADHESION A Comprehensive Analysis of Premarketing and Postmarketing Experiences [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (06): : 1128 - 1134